Ceftobax 1g
Ceftriaxone (1g)

About this product
Best for Broad Spectrum Empiric Infections caused by gram-positive and gram-negative organisms.

Overview
Ceftobax 1g addresses key gaps in current approaches to broad-spectrum empiric infections. As a third-generation cephalosporin, it offers reliable broad-spectrum activity against gram-positive and gram-negative organisms including many beta-lactamase producers, is recognised as a first-line empiric agent in bacterial meningitis given its established CSF penetration, and its long elimination half-life supports convenient dosing.
Indications
Related Products

Aztronaz 1g
Aztreonam (1gm)
Targeted gram-negative coverage against E. coli, Klebsiella, and Pseudomonas for serious UTI, respiratory, intra-abdominal, gynaecological, skin, and bloodstream infections.

Cilbactam 1.5
Ampicillin (1gm) + Sulbactam (500mg)
Broad single-agent coverage against gram-positive, gram-negative, and anaerobic infections, including skin, intra-abdominal, and gynaecological infections such as PID and endometritis.
Partner With Schemic Concepts
Engineer better health outcomes with precision-driven pharmaceuticals
Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it